Media Home | Contact Us

Media Relations Links • About Us • Media Contact • Frequently Asked Questions • Media Site Map CDC News • Press Release Library • Transcripts • MMWR Summaries • B-Roll Footage • Upcoming Events Related Links • Centers at CDC • Data and Statistics • Health Topics A-Z • Image Library • Publications, Software and Other Products • Global Health Odyssey Find your state or local health department HHS News National Health Observances Div. of Media Relations 1600 Clifton Road MS D-14 Atlanta, GA 30333 (404) 639-3286 Fax (404) 639-7394

For Immediate Release May 5, 2006 Contact: CDC Media Relations (404)-639-3286 Fusarium Keratitis Update The Centers for Disease Control and Prevention (CDC) is continuing its investigation on the multi-state outbreak of Fusarium keratitis that may be associated with contact lens use.  As of May 5, 2006, CDC has received reports of 102 confirmed cases, 12 possible cases and 81 cases still under investigation from 31 U.S. states and territories. 65 reports include insufficient evidence to classify them as cases or carry other non-Fusarium diagnoses.  States or territories with at least 1 confirmed or possible case include: AR, AZ, CA, CT, FL, GA, IA, IL, KS, KY, LA, MA, MD, MI, MO, NC, ND, NJ, NY, OH, PA, PR, TN, TX, and VT.  States where all cases under investigation include: IN, MN, NV, OK, OR, and RI. Not all data are available for all confirmed cases. However, as of May 2, 2006, of the 58 confirmed cases for which CDC has complete data: 56 wear contact lenses 32 reported using any B&L ReNu with MoistureLoc 15 reported using any B&L ReNu MultiPlus 7 reported using any unspecified B&L ReNu 3 reported using any AMO product 3 reported using any Alcon product * Some cases reported using more than one type of solution and therefore the solution categories are not mutually exclusive. (Note: Updated case count numbers will be available on Tuesdays and Fridays.  Updated numbers on solution use and other pertinent exposures will be available on Tuesdays.) Summary and Clarifications In addition, CDC would like to clarify some of the information that has appeared in a number of recent media stories on the outbreak.  The following information is known related to this outbreak: Since the first report on this outbreak in the April 10, 2006 Morbidity and Mortality Weekly Report (MMWR), CDC has noted that patients have reported using multiple products, including those manufactured by Bausch & Lomb, Alcon, and Advanced Medical Optics, Inc. At this point, it is too early in the investigation to say whether a particular product or solution may be responsible for the outbreak. Throughout the investigation, the proportion of patients who reported using Bausch & Lomb’s ReNu with MoistureLoc has remained relatively consistent, at around 50-60 percent of confirmed cases. ReNu with MoistureLoc was used by approximately 2.3 million contact lens wearers in the United States, while MultiPlus was used by nearly 11 million contact lens wearers (branded or private label). Fusarium keratitis is naturally occurring disease in the United States. It is not a disease that healthcare providers must report so it is unclear how many cases occur each year in the United States. Disease outbreaks and increased media coverage often raise awareness about particular infections, which, in turn, may 1) increase reports of a disease and 2) result in additional information being identified and collected.  Thus, it is possible that some of the cases currently being investigated represent infection which might normally occur and, as a result, are not related to the outbreak. The risk of getting fungal keratitis from contact lenses remains extremely low. Contact lens wearers who experience unusual redness, pain, tearing, light sensitivity, blurry vision, discharge or swelling should consult their doctor immediately. CDC is continuing its investigation into identifying whether there are specific factors that may have placed people at risk for developing fungal keratitis, including hygiene practices, overnight contact lens wear and specific solutions used. The CDC will provide more information as it becomes available. For more information on fungal keratitis and advice to doctors and consumers, please visit http://www.cdc.gov/ncidod/dhqp/fungal_fusariumKeratitis.html or http://www.fda.gov/oc/opacom/hottopics/contacts.html.

Media Home Page | Accessibility | Privacy Policy | Contact Us CDC Home | Search | Health Topics A-Z This page last updated May 5, 2006 URL: http://www.cdc.gov/media/pressrel/r060505.htm United States Department of Health and Human Services Centers for Disease Control and Prevention Office of Communication Division of Media Relations